Shares of Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.13 and traded as high as $0.17. Enzon Pharmaceuticals shares last traded at $0.15, with a volume of 99,772 shares traded.
Enzon Pharmaceuticals Price Performance
The company has a fifty day moving average price of $0.13 and a two-hundred day moving average price of $0.13. The company has a market capitalization of $11.12 million, a P/E ratio of 15.01 and a beta of 0.27.
Enzon Pharmaceuticals Company Profile
Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.
Further Reading
- Five stocks we like better than Enzon Pharmaceuticals
- What is diluted earnings per share (Diluted EPS)?
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- What Are Dividend Challengers?
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
